NEW YORK, Oct. 3 – Structural proteomics company GeneFormatics said Wednesday that it would work with three Bruker companies to jointly develop proteomics technologies. 

Under the terms so of the deal, GeneFormatics will work on nuclear magnetic resonance spectroscopy with Bruker BioSpin, on X-ray single crystal diffraction with Bruker AXS, and on Matrix Assisted Laser Desorption/Ionization Time-of-Flight mass spectrometry with Bruker Daltonics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.